-
1
-
-
78751546481
-
Use of florbetapir-PET for imaging β-amyloid pathology
-
Clark CM, Schneider JA, Bedell BJ, et al. Use of florbetapir-PET for imaging β-amyloid pathology. JAMA. 2011;305(3):275-283.
-
(2011)
JAMA
, vol.305
, Issue.3
, pp. 275-283
-
-
Clark, C.M.1
Schneider, J.A.2
Bedell, B.J.3
-
2
-
-
78751519245
-
Association of plasma β-amyloid level and cognitive reserve with subsequent cognitive decline
-
Yaffe K, Weston A, Graff-Radford NR, et al. Association of plasma β-amyloid level and cognitive reserve with subsequent cognitive decline. JAMA. 2011;305(3):261-266.
-
(2011)
JAMA
, vol.305
, Issue.3
, pp. 261-266
-
-
Yaffe, K.1
Weston, A.2
Graff-Radford, N.R.3
-
3
-
-
34447322271
-
Research criteria for the diagnosis of Alzheimer's disease: Revising the NINCDS-ADRDA criteria
-
Dubois B, Feldman HH, Jacova C, et al. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol. 2007;6(8):734-746.
-
(2007)
Lancet Neurol
, vol.6
, Issue.8
, pp. 734-746
-
-
Dubois, B.1
Feldman, H.H.2
Jacova, C.3
-
4
-
-
10744232413
-
Imaging brain amyloid in Alzheimer's disease with Pittsburgh compound-B
-
Klunk WE, Engler H, Nordberg A, et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh compound-B. Ann Neurol. 2004;55(3):306-319.
-
(2004)
Ann Neurol
, vol.55
, Issue.3
, pp. 306-319
-
-
Klunk, W.E.1
Engler, H.2
Nordberg, A.3
-
5
-
-
54049129625
-
Pivotal evaluation of the accuracy of a biomarker used for classification or prediction: Standards for study design
-
Pepe MS, Feng ZD, Janes H, Bossuyt PM, Potter JD. Pivotal evaluation of the accuracy of a biomarker used for classification or prediction: standards for study design. J Natl Cancer Inst. 2008;100(20):1432-1438.
-
(2008)
J Natl Cancer Inst
, vol.100
, Issue.20
, pp. 1432-1438
-
-
Pepe, M.S.1
Feng, Z.D.2
Janes, H.3
Bossuyt, P.M.4
Potter, J.D.5
-
6
-
-
35748959415
-
Mixed brain pathologies account for most dementia cases in community-dwelling older persons
-
DOI 10.1212/01.wnl.0000271090.28148.24, PII 0000611420071211000005
-
Schneider JA, Arvanitakis Z, Bang W, Bennett DA. Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology. 2007;69(24):2197-2204. (Pubitemid 350294674)
-
(2007)
Neurology
, vol.69
, Issue.24
, pp. 2197-2204
-
-
Schneider, J.A.1
Arvanitakis, Z.2
Bang, W.3
Bennett, D.A.4
-
7
-
-
66249141245
-
Age, neuropathology, and dementia
-
Medical Research Council Cognitive Function and Ageing Study
-
Savva GM, Wharton SB, Ince PG, Forster G, Matthews FE, Brayne C; Medical Research Council Cognitive Function and Ageing Study. Age, neuropathology, and dementia. N Engl J Med. 2009;360(22):2302-2309.
-
(2009)
N Engl J Med
, vol.360
, Issue.22
, pp. 2302-2309
-
-
Savva, G.M.1
Wharton, S.B.2
Ince, P.G.3
Forster, G.4
Matthews, F.E.5
Brayne, C.6
-
8
-
-
47149112621
-
Long-term effects of aβ42 immunisation in Alzheimer's disease: Follow-up of a randomised, placebo-controlled phase I trial
-
Holmes C, Boche D, Wilkinson D, et al. Long-term effects of Aβ42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial. Lancet. 2008;372(9634):216-223.
-
(2008)
Lancet
, vol.372
, Issue.9634
, pp. 216-223
-
-
Holmes, C.1
Boche, D.2
Wilkinson, D.3
-
9
-
-
72049130805
-
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
-
Jack CR Jr, Knopman DS, Jagust WJ, et al. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol. 2010;9(1):119-128.
-
(2010)
Lancet Neurol
, vol.9
, Issue.1
, pp. 119-128
-
-
Jack Jr., C.R.1
Knopman, D.S.2
Jagust, W.J.3
-
10
-
-
78649846236
-
Statistical methods for assessment of added usefulness of new biomarkers
-
Pencina MJ, D'Agostino RB, Vasan RS. Statistical methods for assessment of added usefulness of new biomarkers. Clin Chem Lab Med. 2010;48(12):1703-1711.
-
(2010)
Clin Chem Lab Med
, vol.48
, Issue.12
, pp. 1703-1711
-
-
Pencina, M.J.1
D'Agostino, R.B.2
Vasan, R.S.3
|